In addition, MERTK contributes to the oncogenesis of a spectrum of human cancers, including hematological malignancies, glioblastoma, NSCLC, melanoma, breast cancer, colon cancer, gastric cancer, and prostate cancer [19]. This evidence concerns the gene MERTK and non-small cell lung carcinoma.